Behavioral Convulsions Faded With Repeated THC in a Sensitive Rabbit Population

A 1976 report described behavioral convulsions after low intravenous cannabinoid doses in a particular rabbit population. The observed events became less severe and disappeared during prolonged THC exposure.

The sensitivity was population-specific

The report concerned New Zealand White rabbits identified as unusually sensitive to stimulant-like cannabinoid effects. It did not establish that all rabbits or all species respond similarly. A selected animal population can be useful for mechanistic research while limiting generalization.

The endpoint was explicitly behavioral

The abstract describes convulsive behavior rather than providing an EEG-based seizure characterization. The observation should not be silently relabeled as a confirmed electrographic epilepsy model. Likewise, low dose is a description within the rabbit protocol, not a human exposure or safety category.

Adaptation does not establish benefit from continued exposure

The fading of events is consistent with tolerance to the measured response. It does not demonstrate an antiepileptic treatment, absence of other persistent effects or safety of escalating exposure. The authors proposed the population as a research model, rather than reporting clinical outcomes.

The report supports a narrow historical observation of sensitivity and adaptation. It cannot determine whether cannabis provokes or prevents seizures in an individual person. Species, selected population, intravenous route and the distinction between behavioral events and electrical confirmation are necessary parts of its interpretation.

Related: interpreting cannabis tolerance claims.

Research cited

Martin P; Consroe P. Cannabinoid induced behavioral convulsions in rabbits. Science (New York, N.Y.) (1976). doi:10.1126/science.982057. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

A 2026 narrative review argues that product potency is not the same as delivered THC dose and that placebo responses remain important among experienced users. Its laboratory framework also distinguishes reduced drug reinforcement from nonspecific sedation. Users can change how they inhale The review notes that participants alter inhalation patterns…

Spread the love

Read Article: A 2026 Cannabis Review Explains Why Potency, Placebo Response and Sedation Need Separate Measures

THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A 1999 rat study found that tolerance weakened THC-related modulation of spinal dynorphin, while antinociception could still occur without the same elevated dynorphin measure. The role of a downstream signal changed with dose and adaptive state. The experiment examined spinal responses The work followed earlier findings linking acute intrathecal THC…

Spread the love

Read Article: THC Antinociception Persisted Without the Same Dynorphin Signal in Tolerant Rats

A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

A 2002 mouse experiment reported fewer antagonist-precipitated withdrawal signs with a Passiflora-derived benzoflavone fraction. The finding concerns a defined experimental preparation and animal model, not a demonstrated treatment for cannabis-use disorder in people. Concurrent and acute interventions were tested Mice received repeated oral THC with or without the fraction. A…

Spread the love

Read Article: A Passiflora-Derived Fraction Reduced THC Withdrawal Signs in a Mouse Model

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us